KWOK-KIN WONG was named chief of hematology and medical oncology at the Perlmutter Cancer Center at NYU Langone Medical Center. Wong will join the Perlmutter faculty in January,. He is a professor of medicine at Harvard Medical School and a clinical oncologist at Dana-Farber Cancer Institute. His research focuses on understanding the pathogenesis and genetic...
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
